Pet imaging with a [68ga]gallium-labelled psma ligand for the diagnosis of prostate cancer: Biodistribution in humans and first evaluation of tumour lesions;Erratum: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: Biodistribution in humans and first evaluation of tumour lesions (European Journal of Nuclear Medicine and Molecular Imaging DOI: 10.1007/s00259-012-2298-2)

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 5, 2013, Pages 797-798

  Afshar Oromieh, A ^a   Malcher, A ^a   Eder, M ^b   Eisenhut, M ^b   Linhart, H G ^b   Hadaschik, B A ^a   Holland Letz, T ^b   Giesel, F L ^a   Kratochwil, C ^a   Haufe, S ^a   Haberkorn, U ^a,b   Zechmann, C M ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Positron emission tomography; PET CT; Prostate specific membrane antigen; Prostate cancer; PSMA

Indexed keywords

ERRATUM; ERROR;

EID: 84885381026     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2298-2     Document Type: Article

References (0)